The company's P/S ratio, surprisingly similar to the industry, implies that investors may be disregarding the company's weaker growth projections, potentially risking future disappointment.
The decreasing ROCE trend and inability to boost sales despite increased capital usage cast doubt on Meinian Onehealth Healthcare Holdings's performance. The market appears doubtful of improvements soon, and the firm shows no multi-bagger characteristics as per analysis.
Meinian Onehealth Healthcare Holdings needs to boost revenue growth to gain more market attention. Advantageous if recovery happens, despite recent good share price performance, focus is on long-term performance.
$JD HEALTH (06618.HK)$launched a "JD Health Fever Clinic Service", offering 24/7 COVID-19-related services to users, including medical consultation and drug prescription, reported The Paper. On the first day after the launch of the "Fever Clinic Service", the volume of medical consultations on the JD HEALTH platform relating to fever, cough and sore throat, etc., ballooned by 5x compared to that in the p...
Meinian Onehealth Healthcare Holdings Stock Forum
On the first day after the launch of the "Fever Clinic Service", the volume of medical consultations on the JD HEALTH platform relating to fever, cough and sore throat, etc., ballooned by 5x compared to that in the p...
No comment yet